FDA Drug Application (022253) for VIMPAT by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number022253
Product Number001
FormTABLET;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIMPAT
Active IngredientLACOSAMIDE

Active IngredientCount
List of drugs with Active Ingredient LACOSAMIDE2


Back to FDA Applications sponsored by UCB INC